Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 118M 104M 96.15M 88.43M 166M 169M 1.15B 448M 5.56B 442M 432M 19.28B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 73.64M 64.76M 60.16M 55.33M 104M 106M 719M 281M 3.48B 276M 270M 12.07B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.72%
Yield 2024 *
-
Yield 2025 -
1 day-3.04%
1 week-0.37%
Current month+11.04%
1 month+19.65%
3 months+58.72%
6 months+111.50%
Current year+156.37%
1 week 225
Extreme 225
240.39
1 month 192.78
Extreme 192.78
248.45
Current year 87.25
Extreme 87.25
248.45
1 year 87.15
Extreme 87.15
248.45
3 years 68.72
Extreme 68.72
248.45
5 years 52.65
Extreme 52.65
248.45
10 years 15
Extreme 15
248.45
Manager TitleAgeSince
Chief Executive Officer 74 03/01/1995
Chief Executive Officer 43 14/06/2011
Director of Finance/CFO - 28/09/2018
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 22/03/2010
Date Insider Type Main position Quantity % Market Cap.
12/09/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
-3.04%-0.37%+111.01%+145.77% 209M
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.84%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.48%+13.66%+30.68% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.55%-1.29%+27.93%+80.87% 14.21B
Weighted average by Cap. -0.18%-0.92%+27.73%+81.89%

Financials

2024 2025
Net sales 12.97B 134M 118M 109M 101M 189M 192M 1.31B 510M 6.33B 503M 492M 21.95B 5.62B 58M 51.01M 47.39M 43.59M 81.74M 83.21M 567M 221M 2.74B 218M 213M 9.51B
Net income 4.21B 43.47M 38.23M 35.52M 32.67M 61.26M 62.36M 425M 166M 2.05B 163M 160M 7.12B 2.5B 25.86M 22.75M 21.13M 19.44M 36.45M 37.1M 253M 98.57M 1.22B 97.1M 95M 4.24B
Net Debt -4.15B -42.88M -37.72M -35.04M -32.23M -60.44M -61.52M -419M -163M -2.03B -161M -158M -7.03B -4.27B -44.05M -38.74M -35.99M -33.1M -62.07M -63.18M -430M -168M -2.08B -165M -162M -7.22B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
23/07/26 225.99 -3.04% 397,859
22/07/26 ₹233.07 -1.91% 447,639
21/07/26 ₹237.60 +1.54% 271,232
20/07/26 ₹233.99 +1.09% 438,766
17/07/26 ₹231.47 -1.03% 288,534
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock